NAGE as of Oct 31 · 17:44 ET

NAGENasdaqMedicinal Chemicals & Botanical Products

Niagen Bioscience, Inc. · Brief

Next report

3 days

Nov 3 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±19.2%implied · straddle

1.882.78

spot 2.33exp Nov 20ATM strike 2.5ATM straddle 0.53IV 110%

Oct 30 close

Expected move

Inputs

Implied vs realized

8 reportsHistory

1 of 6≥ implied

avg implied: ±22.6%
avg realized: ±7.7%

Oct 31 '24—▲+67.91%—

Mar 4 '25—▲+52.68%—

May 7 '25±17.7%▲+9.35%×0.53

Aug 6 '25±16.7%▲+2.23%×0.13

Nov 4 '25±36.6%▼−1.01%×0.03

Q1 FY26±22.3%▲+3.24%×0.15

May 6 '26±14.9%▼−15.69%×1.05

Q2 FY26±27.5%▼−14.70%×0.53

quarterimplied−70%0+70%realized×

Q2 FY26±27.5%▼−14.70%×0.53

May '26±14.9%▼−15.69%×1.05

Q1 FY26±22.3%▲+3.24%×0.15

Nov '25±36.6%▼−1.01%×0.03

Aug '25±16.7%▲+2.23%×0.13

May '25±17.7%▲+9.35%×0.53

2 older reports

Mar '25—▲+52.68%—

Oct '24—▲+67.91%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2

137managers reporting a position in the latest quarterly filings13F · Jun 30 '26

5disclosed supplier and customer ties in SEC filingsSEC filings

Bear2 of 4

14 of 22largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

12.50%of revenue from the largest disclosed customer A.S. Watson GroupSEC filings

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

NAGE report session

Customers 1

AMZNAmazon×0.14

× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes

Oct 20impliedImplied move: ±19.7% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.